Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM)
NCT04491136
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
201
Enrollment
INDUSTRY
Sponsor class
Stopped
Company decision
Conditions
Heart Failure
Interventions
DRUG:
ACEI/ARB
DRUG:
ARNI
Sponsor
Novartis Pharmaceuticals